Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 250 movers: CSR jumps as chip sales impress

Thu, 29th Oct 2009 12:11

CSR, which makes chips for Bluetooth and Global Positioning System (GPS) devices, is sharply higher after third quarter results were better than expected.Pre-tax profits for the period totalled $10.7m compared with a $30.8m over the same period the previous year. Revenues climbed to $219.9m from $205.5m. Bluetooth accounted for $150.4m, GPS for $59.5m.At the time of its second quarter results, CSR issued third quarter guidance of $195m to $215m for revenue. The median forecast of investment analysts' revenue forecasts was $208m.Qinetiq climbs after saying the boss of defence technology group QinetiQ, Graham Love, is being replaced by the former chief of banknote printer De La Rue, Leo Quinn, after eight years at the company.Investment management firm Evolution Group is going well after saying it expects to beat full year profit forecasts this year on the back of strong trading across all of its divisions. Revenues from the Investment Banking arm in the second half of 2009 will be at least double those seen in the first half, reflecting the increased corporate activity.Elsewhere in finance, Fund manager Henderson said assets under management increased 9% to £57.7bn in the third quarter to 30 September 2009 as market conditions continue to improve.National Express is sharply lower after the hard-up bus and train group said it has ended all takeover discussions with rival Stagecoach in order to focus on completing an equity fundraising by the end of this year.Shares in Yell fall back after the cash-strapped Yellow Pages directory publisher Yell Group again extended the deadline for its refinancing. The company, which is looking to restructure £3.8bn of debt, extended the deadline for the third time this week after last night's cut-off passed without success.FTSE 250 - RisersCSR (CSR) 446.60p +11.07%QinetiQ Group (QQ.) 154.80p +8.33%Taylor Wimpey (TW.) 37.77p +5.77%Aquarius Platinum Ltd. (AQP) 274.00p +5.71%Redrow (RDW) 139.80p +5.43%Evolution Group (EVG) 158.50p +4.55%Victrex (VCT) 784.50p +4.32%Barratt Developments (BDEV) 135.30p +4.24%BlueBay Asset Management (BBAY) 368.40p +3.98%Tomkins (TOMK) 162.60p +3.90%FTSE 250 - FallersNational Express Group (NEX) 328.10p -10.01%Laird (LRD) 163.20p -9.33%PartyGaming (PRTY) 221.50p -5.54%Henderson Group (HGG) 127.40p -4.64%PayPoint (PAY) 448.50p -4.17%Melrose Resources (MRS) 357.60p -2.85%Yell Group (YELL) 45.04p -2.81%Imagination Technologies (IMG) 202.50p -2.64%Debenhams (DEB) 77.50p -2.52%PV Crystalox Solar (PVCS) 65.55p -2.16%
More News
8 Jun 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
13 Feb 2020 16:17

Evgen Pharma, Rochester University To Advance SFX-01 For Trial

Evgen Pharma, Rochester University To Advance SFX-01 For Trial

Read more
6 Feb 2020 13:45

Evgen Pharma Hails "Positive" Data From Breast Cancer Drug Research

Evgen Pharma Hails "Positive" Data From Breast Cancer Drug Research

Read more
17 Dec 2019 15:35

Evgen Pharma narrows loss, foresees 'clinical success'

(Sharecast News) - Evgen Pharma on Tuesday reported a narrowed interim loss and said it was confident of clinical success as it continues to develop its SFX-01 treatment.

Read more
17 Dec 2019 11:28

Evgen Pharma Outlook Confident Amid Clinical Success And Trimmed Loss

Evgen Pharma Outlook Confident Amid Clinical Success And Trimmed Loss

Read more
10 Dec 2019 15:59

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
5 Dec 2019 16:36

Evgen Pharma to advance SFX-01 trial with University of Dundee

(Sharecast News) - Clinical-stage drug development company Evgen Pharma has entered into a memorandum of understanding with the University of Dundee, it announced on Thursday, to advance SFX-01 towards a clinical trial in non-alcoholic steatohepatitis (NASH) and liver fibrosis.

Read more
5 Dec 2019 15:19

Evgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 Trials

Evgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 Trials

Read more
11 Nov 2019 12:23

UPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid Development

UPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid Development

Read more
11 Nov 2019 10:22

UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance

UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance

Read more
11 Nov 2019 09:11

Evgen Pharma Shares Drop On "Disappointing" SFX-01 Trial Results

Evgen Pharma Shares Drop On "Disappointing" SFX-01 Trial Results

Read more
23 Sep 2019 13:09

Evgen Pharma "Delighted" With Extended Breast Cancer Treatment Results

Evgen Pharma "Delighted" With Extended Breast Cancer Treatment Results

Read more
23 Sep 2019 10:03

Evgen Pharma upbeat on latest news from SFX-01 studies

(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Monday that five patients who participated in the 'STEM' trial received 'SFX-01' treatment for more than one year, with two of those patients continuing to be treated with SFX-01.

Read more
28 Aug 2019 14:30

Evgen Pharma completes patient study visits in 'SAS' phase 2 trial

(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Wednesday that the last study visit for the last patient entered in the double-blind, placebo-controlled 'SAS' phase 2 clinical trial has taken place.

Read more
28 Aug 2019 12:06

Evgen Pharma Receives Last Patient For Stroke Treatment Drug Trial

(Alliance News) - Evgen Pharma PLC said Wednesday it has entered its last patient in the double-blind, placebo-controlled SAS Phase II clinical trial that is testing its SFX-01 product, aimed at a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.